Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,125,160    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,064,010      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 18 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-10 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-11 4 AS $89.84 $359,360 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-11 4 OE $17.33 $69,320 D/D 4,000 174,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-25 4 OE $17.33 $86,650 D/D 5,000 175,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-25 4 AS $84.44 $422,200 D/D (5,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-26 4 AS $84.00 $420,000 D/D (5,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-26 4 OE $17.33 $86,650 D/D 5,000 175,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-02-24 4 A $0.00 $0 D/D 44,671 215,353 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-03 4 D $93.95 $844,517 D/D (8,989) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-09 4 OE $17.33 $103,980 D/D 6,000 212,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-09 4 AS $90.18 $541,080 D/D (6,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-10 4 AS $91.09 $455,450 D/D (5,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-10 4 OE $17.33 $86,650 D/D 5,000 211,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-13 4 AS $92.68 $463,400 D/D (5,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-13 4 OE $17.33 $86,650 D/D 5,000 211,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-15 4 D $92.50 $1,451,325 D/D (15,690) 190,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-15 4 AS $91.42 $457,100 D/D (5,000) 206,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-15 4 OE $17.33 $86,650 D/D 5,000 211,364 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-16 4 AS $91.96 $459,800 D/D (5,000) 190,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-16 4 OE $71.33 $356,650 D/D 5,000 195,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-22 4 A $0.00 $0 D/D 44,520 235,194 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-04 4 OE $14.39 $43,170 D/D 3,000 238,194 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-25 4 AS $94.00 $470,000 D/D (5,000) 238,194 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-25 4 OE $17.33 $86,650 D/D 5,000 243,194 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-04-27 4 AS $95.72 $478,600 D/D (5,000) 238,194 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18  19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 18 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us